107 related articles for article (PubMed ID: 19383808)
1. Regulation of breast cancer metastasis by atypical chemokine receptors.
Cheng X; Hung MC
Clin Cancer Res; 2009 May; 15(9):2951-3. PubMed ID: 19383808
[TBL] [Abstract][Full Text] [Related]
2. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival.
Feng LY; Ou ZL; Wu FY; Shen ZZ; Shao ZM
Clin Cancer Res; 2009 May; 15(9):2962-70. PubMed ID: 19383822
[TBL] [Abstract][Full Text] [Related]
3. The atypical chemokine receptor CCX-CKR regulates metastasis of mammary carcinoma via an effect on EMT.
Harata-Lee Y; Turvey ME; Brazzatti JA; Gregor CE; Brown MP; Smyth MJ; Comerford I; McColl SR
Immunol Cell Biol; 2014 Nov; 92(10):815-24. PubMed ID: 25027038
[TBL] [Abstract][Full Text] [Related]
4. Generation of a panel of monoclonal antibodies against atypical chemokine receptor CCX-CKR by DNA immunization.
Takatsuka S; Sekiguchi A; Tokunaga M; Fujimoto A; Chiba J
J Pharmacol Toxicol Methods; 2011; 63(3):250-7. PubMed ID: 21184834
[TBL] [Abstract][Full Text] [Related]
5. The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro.
Comerford I; Milasta S; Morrow V; Milligan G; Nibbs R
Eur J Immunol; 2006 Jul; 36(7):1904-16. PubMed ID: 16791897
[TBL] [Abstract][Full Text] [Related]
6. Endogenous expression of the atypical chemokine receptor CCX-CKR (CCRL1) gene in human embryonic kidney (HEK 293) cells.
Salimi P; Esmaeili A; Hashemi M; Behjati M
Mol Cell Biochem; 2016 Jan; 412(1-2):229-33. PubMed ID: 26699909
[TBL] [Abstract][Full Text] [Related]
7. Expression of CCX CKR in pulmonary sarcoidosis.
Kriegova E; Tsyrulnyk A; Arakelyan A; Mrazek F; Ordeltova M; Petzmann S; Zatloukal J; Kolek V; du Bois RM; Popper H; Petrek M
Inflamm Res; 2006 Oct; 55(10):441-5. PubMed ID: 17109071
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CXCR3-mediated chemotaxis by the human chemokine receptor-like protein CCX-CKR.
Vinet J; van Zwam M; Dijkstra IM; Brouwer N; van Weering HR; Watts A; Meijer M; Fokkens MR; Kannan V; Verzijl D; Vischer HF; Smit MJ; Leurs R; Biber K; Boddeke HW
Br J Pharmacol; 2013 Mar; 168(6):1375-87. PubMed ID: 23121557
[TBL] [Abstract][Full Text] [Related]
9. CCX-CKR expression in colorectal cancer and patient survival.
Zhu Y; Tang W; Liu Y; Wang G; Liang Z; Cui L
Int J Biol Markers; 2014 Mar; 29(1):e40-8. PubMed ID: 24338720
[TBL] [Abstract][Full Text] [Related]
10. Chemokine sequestration by atypical chemokine receptors.
Hansell CA; Simpson CV; Nibbs RJ
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1009-13. PubMed ID: 17073739
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes.
Zeng XH; Ou ZL; Yu KD; Feng LY; Yin WJ; Li J; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2011 Feb; 125(3):715-27. PubMed ID: 20369284
[TBL] [Abstract][Full Text] [Related]
12. Atypical chemokine receptors predict lymph node metastasis and prognosis in patients with cervical squamous cell cancer.
Hou T; Liang D; Xu L; Huang X; Huang Y; Zhang Y
Gynecol Oncol; 2013 Jul; 130(1):181-7. PubMed ID: 23603371
[TBL] [Abstract][Full Text] [Related]
13. Chemokines: novel targets for breast cancer metastasis.
Ali S; Lazennec G
Cancer Metastasis Rev; 2007 Dec; 26(3-4):401-20. PubMed ID: 17717637
[TBL] [Abstract][Full Text] [Related]
14. Transient expression of recombinant ACKR4 (CCRL1) gene, an atypical chemokine receptor in human embryonic kidney (HEK 293) cells.
Parsi B; Esmaeili A; Hashemi M; Behjati M
Mol Biol Rep; 2016 Jul; 43(7):583-9. PubMed ID: 27168154
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of atypical chemokine receptor expression in patients with gastric cancer.
Zhu Z; Sun Z; Wang Z; Guo P; Zheng X; Xu H
J Surg Res; 2013 Jul; 183(1):177-83. PubMed ID: 23462454
[TBL] [Abstract][Full Text] [Related]
16. Potential combinatorial effects of recombinant atypical chemokine receptors in breast cancer cell invasion: A research perspective.
Chew AL; Tan WY; Khoo BY
Biomed Rep; 2013 Mar; 1(2):185-192. PubMed ID: 24648916
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential.
Wang J; Ou ZL; Hou YF; Luo JM; Shen ZZ; Ding J; Shao ZM
Oncogene; 2006 Nov; 25(54):7201-11. PubMed ID: 16785997
[TBL] [Abstract][Full Text] [Related]
18. Atypical chemokine receptor 4 (ACKR4/CCX-CKR): A comprehensive exploration across physiological and pathological landscapes in contemporary research.
Naser IH; Hamza AA; Alhili A; Faisal AN; Ali MS; Kadhim NA; Suliman M; Alshahrani MY; Alawadi A
Cell Biochem Funct; 2024 Apr; 42(3):e4009. PubMed ID: 38597217
[TBL] [Abstract][Full Text] [Related]
19. Chemokine decoy receptor d6 plays a negative role in human breast cancer.
Wu FY; Ou ZL; Feng LY; Luo JM; Wang LP; Shen ZZ; Shao ZM
Mol Cancer Res; 2008 Aug; 6(8):1276-88. PubMed ID: 18708360
[TBL] [Abstract][Full Text] [Related]
20. Characterization of mouse CCX-CKR, a receptor for the lymphocyte-attracting chemokines TECK/mCCL25, SLC/mCCL21 and MIP-3beta/mCCL19: comparison to human CCX-CKR.
Townson JR; Nibbs RJ
Eur J Immunol; 2002 May; 32(5):1230-41. PubMed ID: 11981810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]